Structure

Physi-Chem Properties

Molecular Weight:  244.11
Volume:  261.435
LogP:  3.019
LogD:  3.211
LogS:  -2.642
# Rotatable Bonds:  4
TPSA:  60.69
# H-Bond Aceptor:  3
# H-Bond Donor:  3
# Rings:  2
# Heavy Atoms:  3

MedChem Properties

QED Drug-Likeness Score:  0.774
Synthetic Accessibility Score:  1.923
Fsp3:  0.2
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.821
MDCK Permeability:  1.664703268033918e-05
Pgp-inhibitor:  0.108
Pgp-substrate:  0.003
Human Intestinal Absorption (HIA):  0.07
20% Bioavailability (F20%):  0.996
30% Bioavailability (F30%):  0.998

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.04
Plasma Protein Binding (PPB):  96.76547241210938%
Volume Distribution (VD):  0.876
Pgp-substrate:  3.2188124656677246%

ADMET: Metabolism

CYP1A2-inhibitor:  0.968
CYP1A2-substrate:  0.426
CYP2C19-inhibitor:  0.94
CYP2C19-substrate:  0.059
CYP2C9-inhibitor:  0.754
CYP2C9-substrate:  0.965
CYP2D6-inhibitor:  0.951
CYP2D6-substrate:  0.908
CYP3A4-inhibitor:  0.741
CYP3A4-substrate:  0.25

ADMET: Excretion

Clearance (CL):  15.918
Half-life (T1/2):  0.921

ADMET: Toxicity

hERG Blockers:  0.044
Human Hepatotoxicity (H-HT):  0.042
Drug-inuced Liver Injury (DILI):  0.02
AMES Toxicity:  0.408
Rat Oral Acute Toxicity:  0.629
Maximum Recommended Daily Dose:  0.172
Skin Sensitization:  0.954
Carcinogencity:  0.181
Eye Corrosion:  0.645
Eye Irritation:  0.976
Respiratory Toxicity:  0.096

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC119860

Natural Product ID:  NPC119860
Common Name*:   4-[3-(4-Hydroxyphenyl)Propyl]Benzene-1,3-Diol
IUPAC Name:   4-[3-(4-hydroxyphenyl)propyl]benzene-1,3-diol
Synonyms:  
Standard InCHIKey:  OKSKNGMIUSMMMM-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C15H16O3/c16-13-7-4-11(5-8-13)2-1-3-12-6-9-14(17)10-15(12)18/h4-10,16-18H,1-3H2
SMILES:  C(Cc1ccc(cc1)O)Cc1ccc(cc1O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL453448
PubChem CID:   10900865
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0003467] Linear 1,3-diarylpropanoids
        • [CHEMONTID:0003496] Cinnamylphenols

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota n.a. root n.a. PMID[11395279]
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota whole plants Shawnee National Forest, Harrisburg, IL, US n.a. PMID[11678652]
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota whole plants n.a. n.a. PMID[11678652]
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota n.a. n.a. n.a. PMID[12419367]
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota leaves Kaohsiung, Taiwan 2006-SEP PMID[18986201]
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota Fruits n.a. n.a. PMID[19296617]
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota n.a. formosan n.a. PMID[8864236]
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota n.a. n.a. n.a. PMID[9358644]
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO5495 Broussonetia papyrifera Species Moraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT441 Individual Protein Cytochrome P450 19A1 Homo sapiens IC50 > 40.0 ug.mL-1 PMID[511265]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC119860 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9897 High Similarity NPC474839
0.96 High Similarity NPC61885
0.96 High Similarity NPC63698
0.9596 High Similarity NPC248904
0.9412 High Similarity NPC475018
0.9394 High Similarity NPC102216
0.9394 High Similarity NPC30506
0.9381 High Similarity NPC80027
0.932 High Similarity NPC225679
0.932 High Similarity NPC4493
0.932 High Similarity NPC476632
0.932 High Similarity NPC165770
0.93 High Similarity NPC292452
0.9231 High Similarity NPC166995
0.9231 High Similarity NPC43525
0.9216 High Similarity NPC174981
0.92 High Similarity NPC241891
0.9192 High Similarity NPC100340
0.9192 High Similarity NPC143659
0.9167 High Similarity NPC128062
0.9143 High Similarity NPC117846
0.9126 High Similarity NPC33728
0.9126 High Similarity NPC202647
0.9126 High Similarity NPC19808
0.9109 High Similarity NPC134829
0.9091 High Similarity NPC275053
0.9091 High Similarity NPC248573
0.9091 High Similarity NPC161571
0.9057 High Similarity NPC107240
0.902 High Similarity NPC39664
0.902 High Similarity NPC118286
0.902 High Similarity NPC109691
0.902 High Similarity NPC39097
0.902 High Similarity NPC302681
0.902 High Similarity NPC470700
0.8969 High Similarity NPC151715
0.8958 High Similarity NPC45040
0.8952 High Similarity NPC224527
0.8932 High Similarity NPC54844
0.8922 High Similarity NPC246056
0.89 High Similarity NPC10588
0.8889 High Similarity NPC54507
0.8889 High Similarity NPC85292
0.8889 High Similarity NPC229147
0.8889 High Similarity NPC291789
0.8878 High Similarity NPC26244
0.8824 High Similarity NPC244513
0.8824 High Similarity NPC218879
0.8824 High Similarity NPC227458
0.8812 High Similarity NPC284011
0.8812 High Similarity NPC72947
0.8807 High Similarity NPC470760
0.8796 High Similarity NPC185541
0.8796 High Similarity NPC464
0.8788 High Similarity NPC473388
0.8785 High Similarity NPC261343
0.8774 High Similarity NPC268032
0.875 High Similarity NPC158253
0.875 High Similarity NPC204901
0.875 High Similarity NPC232523
0.8738 High Similarity NPC37802
0.8727 High Similarity NPC144343
0.8727 High Similarity NPC131118
0.8725 High Similarity NPC168303
0.8725 High Similarity NPC242342
0.8725 High Similarity NPC85479
0.8725 High Similarity NPC302219
0.8725 High Similarity NPC106396
0.8725 High Similarity NPC313030
0.8725 High Similarity NPC94351
0.8725 High Similarity NPC53051
0.8725 High Similarity NPC222522
0.8725 High Similarity NPC168829
0.8725 High Similarity NPC71002
0.8725 High Similarity NPC146798
0.8725 High Similarity NPC24404
0.8725 High Similarity NPC249828
0.8716 High Similarity NPC115808
0.8713 High Similarity NPC213730
0.8713 High Similarity NPC166761
0.8687 High Similarity NPC274678
0.8673 High Similarity NPC271440
0.8654 High Similarity NPC201662
0.8654 High Similarity NPC12640
0.8654 High Similarity NPC99836
0.8641 High Similarity NPC288411
0.8636 High Similarity NPC277588
0.8627 High Similarity NPC24407
0.8627 High Similarity NPC7686
0.8627 High Similarity NPC91461
0.8627 High Similarity NPC147310
0.8627 High Similarity NPC40258
0.8627 High Similarity NPC11280
0.8627 High Similarity NPC166313
0.8627 High Similarity NPC137415
0.8627 High Similarity NPC294186
0.8627 High Similarity NPC192032
0.8624 High Similarity NPC808
0.8624 High Similarity NPC246760
0.8624 High Similarity NPC84999
0.8614 High Similarity NPC132078
0.8614 High Similarity NPC216468
0.8614 High Similarity NPC78119
0.8614 High Similarity NPC51333
0.8614 High Similarity NPC92730
0.8611 High Similarity NPC23804
0.86 High Similarity NPC132271
0.86 High Similarity NPC292730
0.86 High Similarity NPC216520
0.86 High Similarity NPC82664
0.8585 High Similarity NPC186385
0.8585 High Similarity NPC299568
0.8571 High Similarity NPC223451
0.8571 High Similarity NPC176527
0.8571 High Similarity NPC69006
0.8558 High Similarity NPC99557
0.8558 High Similarity NPC219286
0.8558 High Similarity NPC138942
0.8557 High Similarity NPC318325
0.8557 High Similarity NPC123273
0.8557 High Similarity NPC242240
0.8545 High Similarity NPC141090
0.8545 High Similarity NPC150624
0.8544 High Similarity NPC168393
0.8519 High Similarity NPC473521
0.8515 High Similarity NPC225464
0.8505 High Similarity NPC224870
0.8496 Intermediate Similarity NPC24125
0.8491 Intermediate Similarity NPC105727
0.8491 Intermediate Similarity NPC34864
0.8491 Intermediate Similarity NPC95344
0.8491 Intermediate Similarity NPC58427
0.8491 Intermediate Similarity NPC114392
0.8482 Intermediate Similarity NPC217174
0.8482 Intermediate Similarity NPC191866
0.8468 Intermediate Similarity NPC474933
0.8468 Intermediate Similarity NPC69261
0.8468 Intermediate Similarity NPC33270
0.8454 Intermediate Similarity NPC113460
0.8454 Intermediate Similarity NPC25493
0.844 Intermediate Similarity NPC263753
0.8438 Intermediate Similarity NPC155393
0.8431 Intermediate Similarity NPC128723
0.8421 Intermediate Similarity NPC237667
0.8421 Intermediate Similarity NPC54972
0.8421 Intermediate Similarity NPC476633
0.8421 Intermediate Similarity NPC196976
0.8407 Intermediate Similarity NPC93398
0.8407 Intermediate Similarity NPC159525
0.8407 Intermediate Similarity NPC258979
0.8407 Intermediate Similarity NPC8283
0.8407 Intermediate Similarity NPC472071
0.84 Intermediate Similarity NPC76938
0.8396 Intermediate Similarity NPC305603
0.8396 Intermediate Similarity NPC61033
0.8393 Intermediate Similarity NPC190514
0.8393 Intermediate Similarity NPC74821
0.8384 Intermediate Similarity NPC204210
0.8381 Intermediate Similarity NPC154899
0.8381 Intermediate Similarity NPC233396
0.8378 Intermediate Similarity NPC203113
0.8367 Intermediate Similarity NPC280347
0.8367 Intermediate Similarity NPC177420
0.8367 Intermediate Similarity NPC258219
0.8364 Intermediate Similarity NPC22610
0.8364 Intermediate Similarity NPC473137
0.8364 Intermediate Similarity NPC276737
0.8351 Intermediate Similarity NPC407
0.8351 Intermediate Similarity NPC307235
0.8351 Intermediate Similarity NPC23167
0.8348 Intermediate Similarity NPC100099
0.8348 Intermediate Similarity NPC120172
0.8348 Intermediate Similarity NPC36016
0.8333 Intermediate Similarity NPC77492
0.8333 Intermediate Similarity NPC175313
0.8333 Intermediate Similarity NPC102639
0.8319 Intermediate Similarity NPC188814
0.8319 Intermediate Similarity NPC195262
0.8319 Intermediate Similarity NPC295259
0.8319 Intermediate Similarity NPC158222
0.8319 Intermediate Similarity NPC184302
0.8318 Intermediate Similarity NPC262365
0.8317 Intermediate Similarity NPC8392
0.8317 Intermediate Similarity NPC313650
0.8317 Intermediate Similarity NPC32714
0.8304 Intermediate Similarity NPC50521
0.8304 Intermediate Similarity NPC195466
0.8304 Intermediate Similarity NPC221549
0.8304 Intermediate Similarity NPC244816
0.8302 Intermediate Similarity NPC67250
0.8302 Intermediate Similarity NPC54765
0.8302 Intermediate Similarity NPC92623
0.8302 Intermediate Similarity NPC271274
0.8302 Intermediate Similarity NPC135464
0.83 Intermediate Similarity NPC295295
0.8288 Intermediate Similarity NPC472893
0.8288 Intermediate Similarity NPC53906
0.8286 Intermediate Similarity NPC261573
0.8286 Intermediate Similarity NPC120693
0.8286 Intermediate Similarity NPC8931

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC119860 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9588 High Similarity NPD846 Approved
0.9588 High Similarity NPD940 Approved
0.9091 High Similarity NPD1242 Phase 1
0.8878 High Similarity NPD2860 Approved
0.8878 High Similarity NPD2859 Approved
0.8776 High Similarity NPD2934 Approved
0.8776 High Similarity NPD2933 Approved
0.8614 High Similarity NPD3020 Approved
0.8585 High Similarity NPD4750 Phase 3
0.8393 Intermediate Similarity NPD1548 Phase 1
0.8261 Intermediate Similarity NPD1610 Phase 2
0.8218 Intermediate Similarity NPD1432 Clinical (unspecified phase)
0.8137 Intermediate Similarity NPD1809 Phase 2
0.8137 Intermediate Similarity NPD844 Approved
0.8119 Intermediate Similarity NPD845 Approved
0.8041 Intermediate Similarity NPD111 Approved
0.7934 Intermediate Similarity NPD4908 Phase 1
0.7917 Intermediate Similarity NPD9089 Approved
0.7909 Intermediate Similarity NPD3021 Approved
0.7909 Intermediate Similarity NPD3022 Approved
0.7885 Intermediate Similarity NPD288 Approved
0.783 Intermediate Similarity NPD289 Clinical (unspecified phase)
0.7812 Intermediate Similarity NPD9093 Approved
0.7805 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7797 Intermediate Similarity NPD422 Phase 1
0.7787 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7719 Intermediate Similarity NPD1476 Clinical (unspecified phase)
0.7705 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7664 Intermediate Similarity NPD3028 Approved
0.7642 Intermediate Similarity NPD9273 Approved
0.7581 Intermediate Similarity NPD4625 Phase 3
0.7581 Intermediate Similarity NPD3027 Phase 3
0.7568 Intermediate Similarity NPD2342 Discontinued
0.7544 Intermediate Similarity NPD7635 Approved
0.754 Intermediate Similarity NPD1240 Approved
0.754 Intermediate Similarity NPD1613 Approved
0.754 Intermediate Similarity NPD943 Approved
0.754 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7521 Intermediate Similarity NPD4749 Approved
0.7479 Intermediate Similarity NPD5238 Clinical (unspecified phase)
0.7478 Intermediate Similarity NPD2228 Approved
0.7478 Intermediate Similarity NPD2234 Approved
0.7478 Intermediate Similarity NPD2229 Approved
0.7458 Intermediate Similarity NPD5303 Approved
0.7458 Intermediate Similarity NPD5304 Approved
0.7451 Intermediate Similarity NPD9094 Approved
0.7434 Intermediate Similarity NPD9380 Clinical (unspecified phase)
0.7422 Intermediate Similarity NPD1607 Approved
0.7402 Intermediate Similarity NPD1555 Discontinued
0.7381 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD4589 Approved
0.7323 Intermediate Similarity NPD6405 Approved
0.7323 Intermediate Similarity NPD6407 Approved
0.7321 Intermediate Similarity NPD968 Approved
0.7308 Intermediate Similarity NPD1510 Phase 2
0.7304 Intermediate Similarity NPD6124 Clinical (unspecified phase)
0.7297 Intermediate Similarity NPD9608 Approved
0.7297 Intermediate Similarity NPD9610 Approved
0.7281 Intermediate Similarity NPD1792 Phase 2
0.728 Intermediate Similarity NPD2861 Phase 2
0.7258 Intermediate Similarity NPD1164 Approved
0.7258 Intermediate Similarity NPD1129 Approved
0.7258 Intermediate Similarity NPD1133 Approved
0.7258 Intermediate Similarity NPD1134 Approved
0.7258 Intermediate Similarity NPD1135 Approved
0.7258 Intermediate Similarity NPD1131 Approved
0.7236 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.7236 Intermediate Similarity NPD4659 Approved
0.7213 Intermediate Similarity NPD1201 Approved
0.7203 Intermediate Similarity NPD6671 Approved
0.72 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7197 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7197 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7179 Intermediate Similarity NPD7159 Clinical (unspecified phase)
0.7176 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7168 Intermediate Similarity NPD1445 Approved
0.7168 Intermediate Similarity NPD1444 Approved
0.7167 Intermediate Similarity NPD3091 Approved
0.7154 Intermediate Similarity NPD2561 Approved
0.7154 Intermediate Similarity NPD2562 Approved
0.7154 Intermediate Similarity NPD2568 Approved
0.7143 Intermediate Similarity NPD1549 Phase 2
0.7143 Intermediate Similarity NPD3018 Phase 2
0.713 Intermediate Similarity NPD5451 Approved
0.712 Intermediate Similarity NPD4339 Clinical (unspecified phase)
0.712 Intermediate Similarity NPD4104 Clinical (unspecified phase)
0.712 Intermediate Similarity NPD4103 Phase 2
0.7109 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7107 Intermediate Similarity NPD4093 Discontinued
0.7105 Intermediate Similarity NPD9265 Clinical (unspecified phase)
0.7099 Intermediate Similarity NPD3555 Approved
0.7099 Intermediate Similarity NPD3554 Approved
0.7099 Intermediate Similarity NPD3552 Approved
0.7099 Intermediate Similarity NPD3553 Approved
0.7083 Intermediate Similarity NPD856 Approved
0.7083 Intermediate Similarity NPD9087 Approved
0.7083 Intermediate Similarity NPD16 Approved
0.7073 Intermediate Similarity NPD3092 Approved
0.7049 Intermediate Similarity NPD2286 Discontinued
0.7049 Intermediate Similarity NPD4059 Approved
0.7049 Intermediate Similarity NPD2932 Approved
0.7049 Intermediate Similarity NPD3019 Approved
0.7043 Intermediate Similarity NPD74 Approved
0.7043 Intermediate Similarity NPD2684 Approved
0.7043 Intermediate Similarity NPD9266 Approved
0.7037 Intermediate Similarity NPD3750 Approved
0.7025 Intermediate Similarity NPD1759 Phase 1
0.7025 Intermediate Similarity NPD7330 Discontinued
0.7009 Intermediate Similarity NPD228 Approved
0.7007 Intermediate Similarity NPD7212 Phase 2
0.7007 Intermediate Similarity NPD7213 Phase 3
0.7 Intermediate Similarity NPD7325 Clinical (unspecified phase)
0.6984 Remote Similarity NPD2797 Approved
0.6984 Remote Similarity NPD1470 Approved
0.6984 Remote Similarity NPD3094 Phase 2
0.697 Remote Similarity NPD9088 Approved
0.696 Remote Similarity NPD2982 Phase 2
0.696 Remote Similarity NPD6583 Phase 3
0.696 Remote Similarity NPD2983 Phase 2
0.696 Remote Similarity NPD6582 Phase 2
0.6957 Remote Similarity NPD9264 Approved
0.6957 Remote Similarity NPD7447 Phase 1
0.6957 Remote Similarity NPD9267 Approved
0.6957 Remote Similarity NPD290 Approved
0.6957 Remote Similarity NPD9263 Approved
0.6957 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6949 Remote Similarity NPD5535 Approved
0.6949 Remote Similarity NPD9377 Approved
0.6949 Remote Similarity NPD9379 Approved
0.6942 Remote Similarity NPD317 Approved
0.6942 Remote Similarity NPD1758 Phase 1
0.6942 Remote Similarity NPD318 Approved
0.6935 Remote Similarity NPD1091 Approved
0.6923 Remote Similarity NPD9280 Clinical (unspecified phase)
0.6917 Remote Similarity NPD255 Approved
0.6917 Remote Similarity NPD256 Approved
0.6911 Remote Similarity NPD1751 Approved
0.6891 Remote Similarity NPD5283 Phase 1
0.6885 Remote Similarity NPD2226 Clinical (unspecified phase)
0.6884 Remote Similarity NPD7390 Discontinued
0.688 Remote Similarity NPD2981 Phase 2
0.687 Remote Similarity NPD468 Phase 1
0.6869 Remote Similarity NPD9294 Approved
0.6866 Remote Similarity NPD5406 Approved
0.6866 Remote Similarity NPD5404 Approved
0.6866 Remote Similarity NPD5408 Approved
0.6866 Remote Similarity NPD6100 Approved
0.6866 Remote Similarity NPD6099 Approved
0.6866 Remote Similarity NPD5405 Approved
0.686 Remote Similarity NPD9493 Approved
0.6855 Remote Similarity NPD3421 Phase 3
0.6855 Remote Similarity NPD3847 Discontinued
0.6842 Remote Similarity NPD4978 Clinical (unspecified phase)
0.6835 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6833 Remote Similarity NPD497 Approved
0.6829 Remote Similarity NPD4196 Clinical (unspecified phase)
0.6829 Remote Similarity NPD4235 Clinical (unspecified phase)
0.6818 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6818 Remote Similarity NPD5124 Phase 1
0.6807 Remote Similarity NPD821 Approved
0.6807 Remote Similarity NPD7843 Approved
0.68 Remote Similarity NPD1535 Discovery
0.6797 Remote Similarity NPD858 Approved
0.6797 Remote Similarity NPD602 Approved
0.6797 Remote Similarity NPD859 Approved
0.6797 Remote Similarity NPD599 Approved
0.6797 Remote Similarity NPD6584 Phase 3
0.6791 Remote Similarity NPD651 Clinical (unspecified phase)
0.6777 Remote Similarity NPD709 Approved
0.6774 Remote Similarity NPD9381 Approved
0.6774 Remote Similarity NPD2667 Approved
0.6774 Remote Similarity NPD5846 Approved
0.6774 Remote Similarity NPD6516 Phase 2
0.6774 Remote Similarity NPD2668 Approved
0.6774 Remote Similarity NPD3095 Discontinued
0.6774 Remote Similarity NPD4626 Approved
0.6774 Remote Similarity NPD9384 Approved
0.6772 Remote Similarity NPD3225 Approved
0.6772 Remote Similarity NPD5311 Approved
0.6772 Remote Similarity NPD5310 Approved
0.6763 Remote Similarity NPD1511 Approved
0.6754 Remote Similarity NPD9500 Approved
0.675 Remote Similarity NPD496 Approved
0.675 Remote Similarity NPD495 Approved
0.675 Remote Similarity NPD498 Approved
0.6748 Remote Similarity NPD9545 Approved
0.6746 Remote Similarity NPD9269 Phase 2
0.6746 Remote Similarity NPD1481 Phase 2
0.6742 Remote Similarity NPD4060 Phase 1
0.6742 Remote Similarity NPD2238 Phase 2
0.6741 Remote Similarity NPD2935 Discontinued
0.6741 Remote Similarity NPD2796 Approved
0.6741 Remote Similarity NPD1551 Phase 2
0.6721 Remote Similarity NPD9568 Approved
0.6721 Remote Similarity NPD405 Clinical (unspecified phase)
0.672 Remote Similarity NPD1981 Approved
0.672 Remote Similarity NPD1983 Approved
0.672 Remote Similarity NPD1980 Approved
0.672 Remote Similarity NPD3143 Discontinued
0.6719 Remote Similarity NPD3053 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data